LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 82 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2017. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $437,000 | +11.8% | 58,670 | +4.3% | 0.00% | 0.0% |
| Q4 2016 | $391,000 | -3.5% | 56,249 | +14.3% | 0.00% | 0.0% |
| Q3 2016 | $405,000 | -4.3% | 49,216 | -5.9% | 0.00% | 0.0% |
| Q2 2016 | $423,000 | +84.7% | 52,276 | +16.2% | 0.00% | 0.0% |
| Q1 2016 | $229,000 | -33.2% | 45,000 | +1.3% | 0.00% | 0.0% |
| Q4 2015 | $343,000 | +45.3% | 44,425 | +8.4% | 0.00% | 0.0% |
| Q3 2015 | $236,000 | -31.4% | 40,985 | +9.4% | 0.00% | 0.0% |
| Q2 2015 | $344,000 | – | 37,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,188,331 | $15,209,000 | 19.14% |
| ACUTA CAPITAL PARTNERS, LLC | 3,809,944 | $26,479,000 | 9.85% |
| Avoro Capital Advisors LLC | 4,520,643 | $31,418,000 | 6.35% |
| Broadfin Capital, LLC | 2,638,259 | $18,336,000 | 2.04% |
| Perceptive Advisors | 3,567,553 | $24,794,000 | 1.76% |
| Ghost Tree Capital, LLC | 975,000 | $6,776,000 | 1.63% |
| Opaleye Management Inc. | 300,000 | $2,085,000 | 1.23% |
| Rhenman & Partners Asset Management AB | 650,000 | $4,518,000 | 0.87% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $1,043,000 | 0.39% |
| QVT Financial LP | 1,498,809 | $10,349,000 | 0.31% |